Graduate researcher at Texas A&M University with a background in finance — bridging clinical engineering, market strategy, and data-driven decision-making.
Currently 20 years old, I have navigated a highly accelerated academic path. After graduating high school at 14, I immediately began my undergraduate studies in Finance at UT Dallas, followed by my current pursuit of a Master of Engineering in Biomedical Engineering at Texas A&M University (Expected May 2027).
By the time I complete my Master's at age 21, I will have bridged the gap between complex clinical engineering and high-level strategic finance. I am deeply interested in how rigorous financial modeling and market analysis can optimize decision-making within the medical device industry.
My background allows me to evaluate innovation through both a technical and commercial lens, ensuring that life-saving technologies are not only functional but also strategically viable.
Analyzed market drivers and sterilization impact for a specific surgical device, including competitive landscape and clinical engineering considerations. This research focused on identifying cost-effective materials that maintain integrity through multiple autoclave cycles.
Engineering solutions for patient monitoring and recovery engagement, assessing clinical need and feasibility of a biomedical device concept. The project involves developing a non-invasive wearable sensor suite that tracks physiological markers.
Evaluated remote monitoring strategies and device solutions to improve outcomes and reduce in-person follow-up burden for post-transplant kidney patients using subcutaneous biosensors.
Researched biofilm formation on stainless steel with PEG-Gelatin coatings to improve biocompatibility and inform implantable device design. Analyzed protein adsorption rates to inhibit bacterial colonization.
I am currently actively seeking summer 2027 internships or full-time opportunities where I can apply my unique background in Finance and Biomedical Engineering.
My primary interest lies within the medical device industry, healthcare consulting, and med-tech strategy. I am eager to contribute to teams that value data-driven market analysis and clinical engineering insights.
Let's start a
conversation.